Corbion

Corbion welcomes the opportunity to provide input on the EU Taxonomy and supports its objective of directing capital toward truly sustainable activities. However, the Environmental Delegated Act currently limits eligibility to bio-waste, excluding sustainably sourced primary biomass, which risks slowing innovation and investment in the EU bioeconomy. 1.

Corbion welcomes the Commissions initiative to ensure Europes secure and sustainable access to critical raw materials. The proposal is an essential step towards reducing strategic dependencies on third countries imports and improving the resilience of the EU. We, at Corbion, notably appreciate the introduction of the concept of material substitution within the text.

Corbion welcomes the recommendation in the Communication on Sustainable Carbon Cycles (Communication) that: "at least 20% of the carbon used in the chemical and plastic products should be from sustainable non-fossil sources by 2030". • Evidence put forward in the annex proofs that this percentage could and should be much higher than 20%!

Corbion welcomes the Commission’s initiatives to address unnecessary adverse environmental impacts of products placed on the EU market, while harmonizing industry requirements. The objectives set in the COM proposal for the Ecodesign for sustainable products Regulation (ESPR) are core to Corbion’s priorities of sustainability, circularity, and resource efficiency.

Corbion welcomes the European Commissions proposal for the European Biotech Act I and particularly supports the measures aimed at optimising approval processes under Regulation (EC) No 178/2002. Biotechnology is essential to strengthening EU competitiveness, resilience, and strategic autonomy, and efficient regulatory pathways are critical to ensuring timely market access for innovative biotech solutions.

Corbion welcomes the European Commissions initiative to develop a European Biotech Act and appreciates the opportunity to contribute through this call for evidence. As highlighted in the Communication on Boosting Biotechnology and Biomanufacturing in the EU, biotechnology plays a vital role in strengthening the EUs competitiveness, resilience, and strategic autonomy.

Corbion is the global market leader in lactic acid and its derivatives. Our sustainable solutions provide an alternative to fossil-based ingredients or building blocks across a wide range of industries and we therefore thank the European Commission for the opportunity to react via this consultation to its proposal for a regulation to reform of the EU Emissions Trading System (EU ETS).

The Revision of EU legislation on hazard classification, labelling and packaging of chemicals is crucial for the successful implementation of the Chemicals Strategy for Sustainability (CSS) and we therefore thank the European Commission for the opportunity to provide inputs to the roadmap consultation.

Corbion welcomes the European Commissions initiative to develop a Biotech Act II, complementing the Biotech Act I by establishing a coherent, predictable, and innovation-friendly framework for industrial biotechnology and biomanufacturing in the EU. Europes competitiveness depends not only on innovation but also on the capacity to scale production within the Union.

We thank the European Commission for the possibility to provide inputs to the roadmap consultation regarding the revision of REACH Regulation to help achieve a toxic-free environment as a crucial next step in successfully delivering on the objectives of the Chemicals Strategy for Sustainability (CSS).

Corbion, a leader in sustainable aquaculture nutrition, supports the Commissions 2040 Vision for Aquaculture and Fisheries as a vital opportunity to enhance sustainability. We emphasize the need to incorporate recommendations from the EU report on a Sustainable Algae Industry, particularly the shift from fish-based feed ingredients to algae-based alternatives.

1. Avoid increased administrative burdens for business operators: The administrative burden on companies and the Agency has proven to be more time- and resource-intensive than initially anticipated. Not only the pre-submission phase but also the notification of studies should be proportionate and focused on contributing values to risk assessment. Flexibility should allow companies to use all kinds of studies.

Thank you for the chance to provide input on this consultation. We have the following comments: 1. Avoid increased administrative burdens for business operators: The administrative burden on companies and the Agency has proven to be more time- and resource-intensive than initially anticipated.

The Revision of the Cosmetic Products Regulation (Regulation (EC) No 1223/2009) is crucial for the successful implementation of the CSS and we thank the European Commission for the opportunity to provide inputs to the roadmap consultation. Harmful chemicals We welcome the European Commission’s intention to address the problems with the current CPR.